The Synthetic Biology Can Offer Opportunities for Payers as Consumer Demand for Cost-Effective Pharmaceuticals Rises


Posted December 27, 2018 by coherent123

Synthetic biology involves the design and construction of entirely new biological systems from standardized genetic components, together with the essential redesign of existing life for new purposes.

 
Synthetic biology is a combination of biology and biomedical engineering principles that favors designing and construction of novel biological parts & systems and also the reconstruction of preexisting designs according to specific application requirements. Synthetic biology is extensively used in the field of medical and pharmaceuticals to produce and manufacture improved biological drugs and systems to meet various challenges in the healthcare sector. Synthetic biology offers various opportunities in the field of healthcare such as recreating highly complex pathways, DNA sequences, and natural biological systems.

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/112

Government funding supporting synthetic biology market growth:

Growing demand for synthetic biology products such as synthetic DNA, synthetic genes for treatment of diseases and for developing genetic modified products such as hybrid crop, genetically modified animals for enhancing the nutritional value of the food is also contributing towards the growth of the synthetic biology market. Also, various governments are investing in research and development of novel synthetic biology products. For instance, according to the report from U.S. Trends in Synthetic Biology Research at the Wilson Center, during the period of six years from 2008 to 2014, the U.S. invested around US$ 820 million in research for products in synthetic biology.

Synthetic biology market taxonomy:
By Product Type
• Synthetic DNA
• Synthetic cells
• Synthetic genes
• Chassis organisms
• Genetically modified organisms
• Oligonucleotide Synthesis
By Tool
• Xeno-nucleic Acids (XNA)
• Cloning and Assembly kits
• Oligonucleotides
• Enzymes
By Technology
• Enabling Technologies
◦ Bioinformatics
◦ Site-saturation Mutagenesis
◦ Measurement and Modeling
◦ Microfluidics
◦ Cloning and Sequencing
◦ Gene Synthesis
◦ Genome Engineering
◦ Nanotechnology
• Enabled Technologies
◦ Pathway Engineering
◦ Next-generation Sequencing
By Application
• Environmental Application
◦ Bioremediation
◦ Whole-cell Biosensors
• Industrial Application
◦ Biofuels and Renewable Energy
◦ Industrial Enzymes
◦ Biomaterials and Green Chemicals
• Medical Application
◦ Artificial Tissue and Tissue Regeneration
◦ Pharmaceuticals
◦ Drug Discovery and Therapeutics

Key Players: DuPont, Amyris, Inc., GenScript USA Inc., Integrated DNA Technologies, Intrexon Corporation, New England Biolabs, Inc., Thermo Fisher Scientific, Inc., Synthetic Genomics, Inc., Royal DSM, and Novozymes.

Request Customization: https://www.coherentmarketinsights.com/insight/request-customization/112

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommen
dations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By coherent
Country India
Categories Health
Tags Synthetic Biology Market, , ,Synthetic Biology growth, , ,Synthetic Biology outlook , Synthetic Biology trends , Synthetic Biology insights
Last Updated December 27, 2018